| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF13B ABCA13 ATP8A2 LRRK2 SMARCAD1 RAB14 TRIM23 ATP8A1 RAB34 GNA14 SMPDL3A EIF2S3 ATF7IP EIF4A1 ABCC2 ASCC3 ABCC10 | 9.59e-05 | 775 | 153 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 1.02e-04 | 97 | 153 | 6 | GO:0008081 | |
| GeneOntologyMolecularFunction | clathrin binding | 1.22e-04 | 63 | 153 | 5 | GO:0030276 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 1.29e-04 | 34 | 153 | 4 | GO:0008266 | |
| GeneOntologyMolecularFunction | calcium ion binding | MATN3 FSTL5 PLCD4 PCDHA4 PCDHA2 ITGB1 F9 ITPR1 EFHC2 SYT11 SLIT3 PLCB1 SYT4 PLCB4 PLS3 ADGRL3 | 2.10e-04 | 749 | 153 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 2.21e-04 | 39 | 153 | 4 | GO:0008187 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF13B ABCA13 ATP8A2 LRRK2 SMARCAD1 RAB14 TRIM23 ATP8A1 RAB34 GNA14 SMPDL3A EIF2S3 ATF7IP EIF4A1 ABCC2 ASCC3 ABCC10 | 2.46e-04 | 839 | 153 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF13B ABCA13 ATP8A2 LRRK2 SMARCAD1 RAB14 TRIM23 ATP8A1 RAB34 GNA14 SMPDL3A EIF2S3 ATF7IP EIF4A1 ABCC2 ASCC3 ABCC10 | 2.50e-04 | 840 | 153 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF13B ABCA13 ATP8A2 LRRK2 SMARCAD1 RAB14 TRIM23 ATP8A1 RAB34 GNA14 SMPDL3A EIF2S3 ATF7IP EIF4A1 ABCC2 ASCC3 ABCC10 | 2.50e-04 | 840 | 153 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 5.75e-04 | 5 | 153 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF13B ABCA13 ATP8A2 SMARCAD1 ATP8A1 SMPDL3A ATF7IP EIF4A1 ABCC2 ASCC3 ABCC10 | 6.06e-04 | 441 | 153 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF13B MYO1D ABCA13 ATP8A2 SMARCAD1 ATP8A1 MYH14 SMPDL3A ATF7IP EIF4A1 ABCC2 ASCC3 ABCC10 | 9.08e-04 | 614 | 153 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 1.01e-03 | 26 | 153 | 3 | GO:0004435 | |
| GeneOntologyMolecularFunction | aminophospholipid flippase activity | 1.19e-03 | 7 | 153 | 2 | GO:0015247 | |
| GeneOntologyBiologicalProcess | import into cell | EHBP1 CACNA1D CLTCL1 ANK3 MYO1D ABCA13 LRRK2 ENTHD1 SPG11 RAB14 ITGB1 TRIP10 SLC12A5 NOD2 ATP8A1 RAB34 SYT11 KCNJ10 KCNJ15 RNF216 SYT4 PRKCE | 1.18e-05 | 1074 | 151 | 22 | GO:0098657 |
| GeneOntologyBiologicalProcess | endocytosis | EHBP1 CLTCL1 ANK3 MYO1D ABCA13 LRRK2 ENTHD1 SPG11 RAB14 ITGB1 TRIP10 NOD2 ATP8A1 RAB34 SYT11 RNF216 SYT4 PRKCE | 3.61e-05 | 827 | 151 | 18 | GO:0006897 |
| GeneOntologyBiologicalProcess | phagosome maturation involved in apoptotic cell clearance | 5.32e-05 | 2 | 151 | 2 | GO:0090386 | |
| GeneOntologyBiologicalProcess | phagolysosome assembly involved in apoptotic cell clearance | 5.32e-05 | 2 | 151 | 2 | GO:0090387 | |
| GeneOntologyBiologicalProcess | phagosome maturation | 7.45e-05 | 31 | 151 | 4 | GO:0090382 | |
| GeneOntologyCellularComponent | dendrite | GIPC1 CACNA1D PDE2A ANK3 MYO1D DSCAM LRRK2 SPG11 ITGB1 PABPC1 SLC12A5 ITPR1 SYT11 SYT4 ABHD13 PLCB4 CAPRIN1 | 1.73e-04 | 858 | 152 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | GIPC1 CACNA1D PDE2A ANK3 MYO1D DSCAM LRRK2 SPG11 ITGB1 PABPC1 SLC12A5 ITPR1 SYT11 SYT4 ABHD13 PLCB4 CAPRIN1 | 1.78e-04 | 860 | 152 | 17 | GO:0097447 |
| Domain | - | 2.62e-05 | 148 | 150 | 8 | 2.60.40.150 | |
| Domain | C2_dom | 5.45e-05 | 164 | 150 | 8 | IPR000008 | |
| Domain | C2 | 9.11e-05 | 131 | 150 | 7 | PF00168 | |
| Domain | C2 | 1.21e-04 | 137 | 150 | 7 | SM00239 | |
| Domain | C2 | 1.51e-04 | 142 | 150 | 7 | PS50004 | |
| Domain | P-loop_NTPase | KIF13B MYO1D ABCA13 SPEF2 LRRK2 SMARCAD1 RAB14 AK7 TRIM23 NOD2 RAB34 GNA14 MYH14 EIF2S3 EIF4A1 ABCC2 ASCC3 ABCC10 | 1.59e-04 | 848 | 150 | 18 | IPR027417 |
| Domain | PLC-beta_CS | 1.91e-04 | 3 | 150 | 2 | IPR009535 | |
| Domain | DUF1154 | 1.91e-04 | 3 | 150 | 2 | PF06631 | |
| Domain | EF-hand_like | 2.15e-04 | 15 | 150 | 3 | PF09279 | |
| Domain | PI-PLC-Y | 2.15e-04 | 15 | 150 | 3 | PF00387 | |
| Domain | PLCYc | 2.15e-04 | 15 | 150 | 3 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 2.15e-04 | 15 | 150 | 3 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 2.15e-04 | 15 | 150 | 3 | PS50008 | |
| Domain | PI-PLC_fam | 2.15e-04 | 15 | 150 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 2.15e-04 | 15 | 150 | 3 | IPR015359 | |
| Domain | PI-PLC-X | 3.79e-04 | 18 | 150 | 3 | PF00388 | |
| Domain | PLCXc | 3.79e-04 | 18 | 150 | 3 | SM00148 | |
| Domain | PLC-beta | 3.80e-04 | 4 | 150 | 2 | IPR016280 | |
| Domain | PIPLC_X_DOMAIN | 4.48e-04 | 19 | 150 | 3 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 4.48e-04 | 19 | 150 | 3 | IPR000909 | |
| Domain | Quino_amine_DH_bsu | 6.99e-04 | 22 | 150 | 3 | IPR011044 | |
| Domain | - | 9.41e-04 | 6 | 150 | 2 | 2.40.50.90 | |
| Domain | Staphylococal_nuclease_OB-fold | 9.41e-04 | 6 | 150 | 2 | IPR016071 | |
| Domain | - | ABCA13 SPEF2 LRRK2 SMARCAD1 RAB14 AK7 TRIM23 NOD2 RAB34 GNA14 EIF2S3 EIF4A1 ABCC2 ASCC3 ABCC10 | 9.98e-04 | 746 | 150 | 15 | 3.40.50.300 |
| Domain | - | 1.03e-03 | 25 | 150 | 3 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 1.03e-03 | 25 | 150 | 3 | IPR017946 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 2.47e-05 | 22 | 112 | 4 | M39795 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 5.63e-05 | 10 | 112 | 3 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 7.69e-05 | 11 | 112 | 3 | M49033 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 1.29e-04 | 33 | 112 | 4 | M39745 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.32e-04 | 13 | 112 | 3 | M47656 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | GIPC1 KRT1 ANK3 RTCB MTMR1 MSI1 PAF1 RAB14 ANKHD1 GDI2 PABPC1 MSI2 CIRBP NOP58 PA2G4 EIF2S3 EIF4A1 USP7 USP39 ASCC3 DNAJA1 CNOT1 CAPRIN1 PLS3 | 2.53e-10 | 1149 | 153 | 24 | 35446349 |
| Pubmed | GIPC1 KIF13B PDE2A ANK3 DSCAM ARHGEF18 PAF1 RAB14 GDI2 PABPC1 SLC12A5 ATF7IP EIF4A1 KCNJ10 PLCB1 PRKCE RIMS1 HERC2 DNAJA1 CNOT1 CAPRIN1 CUX1 | 2.90e-10 | 963 | 153 | 22 | 28671696 | |
| Pubmed | MYO1D RTCB RPN2 ITGB1 GDI2 PABPC1 NOP58 EIF2S3 EIF4A1 USP7 ASCC3 DNAJA1 CNOT1 CAPRIN1 PLS3 | 4.40e-09 | 484 | 153 | 15 | 31995728 | |
| Pubmed | ANK3 RPN2 MTMR1 SPG11 SMARCAD1 PAF1 ITGB1 NDUFB10 TMCC3 ITPR1 NOP58 DPP9 PA2G4 EIF2S3 UGGT2 TYW1 IFT80 ALDH2 HERC2 ASCC3 DNAJA1 CAPRIN1 PLS3 CUX1 RBM34 | 8.46e-09 | 1487 | 153 | 25 | 33957083 | |
| Pubmed | KRT1 CLTCL1 RTCB RPN2 TUBGCP2 ITGB1 NDUFB10 ITPR1 MSI2 NOD2 NOP58 PA2G4 EIF2S3 EIF4A1 USP7 USP39 ALDH2 ASCC3 DNAJA1 CNOT1 CAPRIN1 PLS3 CUX1 RBM34 | 2.06e-08 | 1440 | 153 | 24 | 30833792 | |
| Pubmed | KIF13B KRT1 INTU CLTCL1 MYO1D RPN2 SPEF2 SPG11 CAGE1 RAB14 RNF17 PABPC1 MIPOL1 MYH14 CEP112 FAM186A SNX25 EIF4A1 UGGT2 RIMS1 ALDH2 ABCC2 DNAJA1 CUX1 | 2.11e-08 | 1442 | 153 | 24 | 35575683 | |
| Pubmed | MYO1D RTCB RPN2 ANKHD1 GDI2 PABPC1 NOP58 MYH14 EIF4A1 USP7 HERC2 ASCC3 DNAJA1 CNOT1 CAPRIN1 RBM34 | 3.53e-08 | 653 | 153 | 16 | 22586326 | |
| Pubmed | GIPC1 KRT1 CLTCL1 RPN2 TUBGCP2 ITGB1 PABPC1 ITPR1 PARP4 NOP58 ATP8A1 MYH14 PA2G4 GLE1 EIF4A1 ABHD13 HERC2 ASCC3 DNAJA1 CNOT1 CAPRIN1 | 4.89e-08 | 1168 | 153 | 21 | 19946888 | |
| Pubmed | 6.13e-08 | 24 | 153 | 5 | 10843712 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYO1D RTCB RPN2 VPS13C SMARCAD1 ANKHD1 GDI2 PABPC1 USP19 NOP58 MYH14 PA2G4 EIF2S3 EIF4A1 USP7 USP39 ALDH2 TDRD6 DNAJA1 CNOT1 CAPRIN1 PLS3 RBM34 | 7.49e-08 | 1425 | 153 | 23 | 30948266 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.05e-07 | 202 | 153 | 9 | 33005030 | |
| Pubmed | KRT1 ANK3 DSCAM VPS13C SCYL3 LRRK2 TEX9 RAB14 ITGB1 PKHD1L1 TRIM23 USP19 DOCK5 EIF2S3 ATF7IP CUX1 | 3.69e-07 | 777 | 153 | 16 | 35844135 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.90e-07 | 208 | 153 | 9 | 33230847 | |
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 4.73e-07 | 15 | 153 | 4 | 28578927 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | PDE2A MTMR1 RAB14 PABPC1 TLR8 TRIM23 SLC12A5 ITPR1 ATP8A1 BRCA2 EIF2S3 PRKCE ALDH2 TDRD6 | 7.12e-07 | 621 | 153 | 14 | 22794259 |
| Pubmed | KRT1 MYO1D RTCB PABPC1 MSI2 CIRBP NOP58 RAB34 PA2G4 EIF2S3 EIF4A1 USP39 DNAJA1 CAPRIN1 RBM34 | 8.23e-07 | 725 | 153 | 15 | 27025967 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | RTCB ANKHD1 CRABP2 GDI2 PARP4 NOP58 MYH14 EIF4A1 USP7 ALDH2 ABCC2 DNAJA1 CNOT1 PLS3 CUX1 | 9.27e-07 | 732 | 153 | 15 | 34732716 |
| Pubmed | GIPC1 PDE2A SGTB ANK3 DSCAM SMARCAD1 TRIM5 FAN1 MIPOL1 ZNF605 MYH14 HECTD2 EIF4A1 USP7 RNF216 SYT4 HERC2 DNAJA1 CAPRIN1 CUX1 | 1.01e-06 | 1285 | 153 | 20 | 35914814 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT1 RTCB RPN2 SMARCAD1 PAF1 RAB14 ANKHD1 ITGB1 TRIP10 PABPC1 MSI2 CIRBP NOP58 PA2G4 EIF2S3 EIF4A1 USP7 USP39 DNAJA1 CAPRIN1 PLS3 | 1.13e-06 | 1415 | 153 | 21 | 28515276 |
| Pubmed | KRT1 PDE2A ANK3 MYO1D RTCB MTMR1 RAB14 GDI2 PABPC1 SLC12A5 ATP8A1 MYH14 EIF2S3 USP7 PRKCE RIMS1 ALDH2 PRKAG2 CNOT1 CAPRIN1 PLS3 | 1.35e-06 | 1431 | 153 | 21 | 37142655 | |
| Pubmed | Reactive astrogliosis causes the development of spontaneous seizures. | 1.65e-06 | 6 | 153 | 3 | 25716834 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | RTCB RPN2 MSI1 PABPC1 NOP58 EIF2S3 USP7 USP39 ASCC3 DNAJA1 CAPRIN1 RBM34 | 1.80e-06 | 486 | 153 | 12 | 30940648 |
| Pubmed | KRT1 RPN2 VPS13C RAB14 ITGB1 GDI2 PABPC1 CIRBP NOP58 MYH14 PA2G4 EIF2S3 EIF4A1 DNAJA1 CAPRIN1 | 2.88e-06 | 803 | 153 | 15 | 36517590 | |
| Pubmed | Genetic dissection of gustatory sensitivity to bitterness (sucrose octaacetate) in mice. | 2.88e-06 | 7 | 153 | 3 | 10609087 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT1 MYO1D RTCB RPN2 TUBGCP2 RAB14 PABPC1 NDUFB10 NOP58 PA2G4 EIF2S3 EIF4A1 USP7 USP39 ASCC3 DNAJA1 CAPRIN1 PLS3 RBM34 | 2.95e-06 | 1257 | 153 | 19 | 36526897 |
| Pubmed | 2.99e-06 | 23 | 153 | 4 | 9730685 | ||
| Pubmed | 2.99e-06 | 23 | 153 | 4 | 9278385 | ||
| Pubmed | RTCB RPN2 GDI2 PABPC1 CIRBP NOP58 PA2G4 EIF2S3 USP7 USP39 ASCC3 DNAJA1 CNOT1 CAPRIN1 PLS3 | 3.15e-06 | 809 | 153 | 15 | 32129710 | |
| Pubmed | KRT1 CLTCL1 RTCB RPN2 CLEC5A MSI1 PAF1 RAB14 PABPC1 AK7 MSI2 CIRBP NOP58 MYH14 EIF4A1 DNAJA1 CAPRIN1 PLS3 | 3.52e-06 | 1153 | 153 | 18 | 29845934 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYO1D RPN2 HAUS3 PAF1 ANKHD1 PABPC1 PARP4 NOP58 RAB34 MYH14 ASCC3 DNAJA1 CNOT1 CAPRIN1 | 4.24e-06 | 724 | 153 | 14 | 36232890 |
| Pubmed | CACNA1D USP19 MKNK1 HECTD2 HERC2 DNAJA1 CAPRIN1 UTY CUX1 ABCC10 | 6.28e-06 | 371 | 153 | 10 | 15747579 | |
| Pubmed | RTCB MSI1 GDI2 PABPC1 MSI2 CIRBP PARP4 NOP58 PA2G4 EIF2S3 EIF4A1 USP7 USP39 DNAJA1 CAPRIN1 RBM34 | 6.51e-06 | 971 | 153 | 16 | 33306668 | |
| Pubmed | 6.88e-06 | 9 | 153 | 3 | 7589147 | ||
| Pubmed | Phospholipase C-beta 1 is a GTPase-activating protein for Gq/11, its physiologic regulator. | 6.88e-06 | 9 | 153 | 3 | 1322796 | |
| Pubmed | 6.88e-06 | 9 | 153 | 3 | 10501179 | ||
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | ANK3 GDI2 PABPC1 MSI2 CIRBP EIF2S3 EIF4A1 SDC3 RIMS1 ALDH2 DNAJA1 CAPRIN1 | 7.36e-06 | 558 | 153 | 12 | 35063084 |
| Pubmed | MYO1D RTCB MSI1 PABPC1 MSI2 NOP58 EIF2S3 USP7 DNAJA1 CAPRIN1 PLS3 | 7.99e-06 | 469 | 153 | 11 | 37314180 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EHBP1 INTU ANK3 VPS13C ARHGEF18 ITGB1 MSI2 MIPOL1 DOCK5 DPP9 FAM13A MYH14 EXOC6B SDC3 PRKCE PLCB4 RIMS1 PRKAG2 CNOT1 CUX1 | 9.18e-06 | 1489 | 153 | 20 | 28611215 |
| Pubmed | Expression of phospholipase C isozymes by murine B lymphocytes. | 9.79e-06 | 10 | 153 | 3 | 2033248 | |
| Pubmed | KRT1 RTCB MSI1 RAB14 ANKHD1 ITGB1 PABPC1 MSI2 CIRBP PARD6B NOP58 MYH14 PA2G4 HERC2 ASCC3 CNOT1 CAPRIN1 PLS3 RBM34 | 1.01e-05 | 1371 | 153 | 19 | 36244648 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CLTCL1 ANK3 RTCB RPN2 RAB14 CRABP2 GDI2 PABPC1 NOP58 MYH14 EIF2S3 EIF4A1 USP7 CNOT1 | 1.44e-05 | 807 | 153 | 14 | 30575818 |
| Pubmed | CLTCL1 MYO1D ANKHD1 GDI2 PABPC1 ATP8A1 PA2G4 EIF2S3 DNAJA1 PLS3 | 1.52e-05 | 411 | 153 | 10 | 36652389 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | KIF13B RTCB SMARCAD1 ANKHD1 TRIP10 MSI2 NOP58 PA2G4 EIF2S3 EIF4A1 ASCC3 DNAJA1 CNOT1 | 1.54e-05 | 704 | 153 | 13 | 29955894 |
| Pubmed | KRT1 RTCB ITGB1 GDI2 PABPC1 MSI2 CIRBP NOP58 PA2G4 EIF2S3 EIF4A1 USP39 CNOT1 | 1.61e-05 | 707 | 153 | 13 | 19738201 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | RTCB RPN2 RAB14 ITGB1 NOP58 MYH14 PA2G4 EIF2S3 USP7 USP39 DNAJA1 CAPRIN1 | 1.70e-05 | 607 | 153 | 12 | 39147351 |
| Pubmed | KRT1 RTCB RAB14 ANKHD1 PABPC1 CIRBP NOP58 MYH14 EIF2S3 USP7 HEPHL1 CAPRIN1 RBM34 | 1.70e-05 | 711 | 153 | 13 | 33022573 | |
| Pubmed | GIPC1 RTCB RPN2 SMARCAD1 RAB14 ANKHD1 ITGB1 PABPC1 CEP112 EIF2S3 EIF4A1 UGGT2 PLCB4 DNAJA1 CNOT1 CAPRIN1 PLS3 RBM34 | 1.73e-05 | 1297 | 153 | 18 | 33545068 | |
| Pubmed | Aldehyde dehydrogenase 2 activation and coevolution of its εPKC-mediated phosphorylation sites. | 1.92e-05 | 2 | 153 | 2 | 28056995 | |
| Pubmed | Toll-like Receptor 8 Stability Is Regulated by Ring Finger 216 in Response to Circulating MicroRNAs. | 1.92e-05 | 2 | 153 | 2 | 31385713 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 32245259 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 26434682 | ||
| Pubmed | Cold-inducible RNA-binding protein modulates circadian gene expression posttranscriptionally. | 1.92e-05 | 2 | 153 | 2 | 22923437 | |
| Pubmed | Activation of PKCε-ALDH2 Axis Prevents 4-HNE-Induced Pain in Mice. | 1.92e-05 | 2 | 153 | 2 | 34944441 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 8995301 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 15949469 | ||
| Pubmed | The RNA-binding protein Musashi is required intrinsically to maintain stem cell identity. | 1.92e-05 | 2 | 153 | 2 | 16717192 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 19714342 | ||
| Pubmed | Theoretical studies on RNA recognition by Musashi 1 RNA-binding protein. | 1.92e-05 | 2 | 153 | 2 | 35840700 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 35442721 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 36972292 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 37481823 | ||
| Pubmed | Assessment of MUSASHI 1 and MUSASHI 2 expression in spermatozoa and testicular tissue. | 1.92e-05 | 2 | 153 | 2 | 34309875 | |
| Pubmed | Interplay between the RNA binding-protein Musashi and developmental signaling pathways. | 1.92e-05 | 2 | 153 | 2 | 31692135 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 34768932 | ||
| Pubmed | Crystal and solution structures of human oncoprotein Musashi-2 N-terminal RNA recognition motif 1. | 1.92e-05 | 2 | 153 | 2 | 31603583 | |
| Pubmed | Expression of RNA-binding protein Musashi in hair follicle development and hair cycle progression. | 1.92e-05 | 2 | 153 | 2 | 16400011 | |
| Pubmed | The Musashi proteins MSI1 and MSI2 are required for photoreceptor morphogenesis and vision in mice. | 1.92e-05 | 2 | 153 | 2 | 33168629 | |
| Pubmed | Msi RNA-binding proteins control reserve intestinal stem cell quiescence. | 1.92e-05 | 2 | 153 | 2 | 27799368 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 11927671 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 19913552 | ||
| Pubmed | Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state. | 1.92e-05 | 2 | 153 | 2 | 25380226 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 22113197 | ||
| Pubmed | Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets. | 1.92e-05 | 2 | 153 | 2 | 28143872 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 24475116 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 18942751 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 37943872 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 26131972 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 12407178 | ||
| Pubmed | RNA binding proteins in spermatogenesis: an in depth focus on the Musashi family. | 1.92e-05 | 2 | 153 | 2 | 25851660 | |
| Pubmed | Schwann cells secrete a novel collagen-like adhesive protein that binds N-syndecan. | 1.92e-05 | 2 | 153 | 2 | 8662884 | |
| Pubmed | Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins. | 1.92e-05 | 2 | 153 | 2 | 30097032 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 15664177 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 2.02e-05 | 258 | 153 | 8 | 37794589 | |
| Pubmed | KIF13B MYO1D RTCB ANKHD1 PABPC1 MSI2 CIRBP NOP58 PA2G4 EIF4A1 SYT4 USP39 ASCC3 | 2.03e-05 | 723 | 153 | 13 | 34133714 | |
| Pubmed | 2.29e-05 | 128 | 153 | 6 | 30995482 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | KRT1 MYO1D RTCB PABPC1 NOP58 MYH14 EIF2S3 EIF4A1 HERC2 DNAJA1 CAPRIN1 CUX1 | 2.30e-05 | 626 | 153 | 12 | 33644029 |
| Pubmed | Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. | 2.37e-05 | 38 | 153 | 4 | 12482669 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 2.44e-05 | 265 | 153 | 8 | 19240061 | |
| Pubmed | NDUFAF5 MYO1D RTCB RPN2 SPG11 PAF1 ANKHD1 GDI2 PABPC1 CIRBP EIF4A1 USP7 IFT80 ASCC3 DNAJA1 CAPRIN1 PLS3 RBM34 | 2.53e-05 | 1335 | 153 | 18 | 29229926 | |
| Pubmed | RPN2 TUBGCP2 PABPC1 USP19 NOP58 EIF2S3 USP7 USP39 ASCC3 DNAJA1 CNOT1 PLS3 | 2.76e-05 | 638 | 153 | 12 | 33239621 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | GIPC1 TUBGCP2 RAB14 ITGB1 PABPC1 MIPOL1 MYH14 CEP112 USP7 UGGT2 HERC2 ASCC3 CUX1 | 3.13e-05 | 754 | 153 | 13 | 33060197 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | EHBP1 NDUFAF5 MYO1D VPS13C MSI1 ITGB1 GDI2 NDUFB10 TMCC3 USP19 ITPR1 MSI2 NOP58 ALDH2 HERC2 DNAJA1 CAPRIN1 CUX1 RBM34 | 3.36e-05 | 1496 | 153 | 19 | 32877691 |
| Pubmed | KRT1 ABCA13 RAB14 PABPC1 ITPR1 NOP58 BRCA2 MYH14 EIF4A1 USP39 ALDH2 PLS3 | 3.41e-05 | 652 | 153 | 12 | 31180492 | |
| Pubmed | ANK3 RTCB TEAD4 PAF1 ANKHD1 NOP58 USP7 ASCC3 CNOT1 PLS3 CUX1 | 3.41e-05 | 549 | 153 | 11 | 38280479 | |
| Pubmed | 3.65e-05 | 15 | 153 | 3 | 11118617 | ||
| Pubmed | GIPC1 RTCB PAF1 PABPC1 NOP58 PA2G4 EIF2S3 EIF4A1 USP7 USP39 CAPRIN1 PLS3 | 3.83e-05 | 660 | 153 | 12 | 32780723 | |
| Pubmed | 4.26e-05 | 44 | 153 | 4 | 20200978 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GIPC1 MYO1D VPS13C LRRK2 RAB14 CRABP2 ITGB1 GDI2 TRIP10 PARD6B PARP4 RAB34 MYH14 ALDH2 DNAJA1 | 4.54e-05 | 1016 | 153 | 15 | 19056867 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO1D RTCB RAB14 ITGB1 PABPC1 NOP58 MYH14 PA2G4 GLE1 EIF4A1 USP39 HERC2 ASCC3 DNAJA1 CNOT1 | 4.96e-05 | 1024 | 153 | 15 | 24711643 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | HAUS3 TUBGCP2 GDI2 PABPC1 TRIM5 ITPR1 PARD6B NOP58 PA2G4 EIF4A1 USP39 HERC2 DNAJA1 CNOT1 CAPRIN1 PLS3 | 5.34e-05 | 1155 | 153 | 16 | 20360068 |
| Interaction | LGALS9 interactions | MYO1D RTCB RPN2 SLC26A2 ITGB1 GDI2 PABPC1 NOP58 EIF2S3 EIF4A1 USP7 USP39 ABCC2 ASCC3 DNAJA1 CNOT1 CAPRIN1 PLS3 | 4.48e-07 | 588 | 151 | 18 | int:LGALS9 |
| Interaction | LRRC31 interactions | KRT1 RPN2 TRIP10 DOCK5 PARP4 MYH14 HERC2 ASCC3 CNOT1 CAPRIN1 | 3.44e-06 | 205 | 151 | 10 | int:LRRC31 |
| Interaction | BAP1 interactions | GIPC1 KRT1 ANK3 RTCB MTMR1 MSI1 PAF1 RAB14 ANKHD1 GDI2 PABPC1 MSI2 CIRBP NOP58 BRCA2 PA2G4 EIF2S3 EIF4A1 USP7 USP39 KDM1B ASCC3 DNAJA1 CNOT1 CAPRIN1 PLS3 | 4.85e-06 | 1314 | 151 | 26 | int:BAP1 |
| Interaction | ARHGAP30 interactions | 1.08e-05 | 19 | 151 | 4 | int:ARHGAP30 | |
| Interaction | SHANK3 interactions | PDE2A ANK3 SCYL3 RAB14 TRIP10 SLC12A5 ITPR1 MIPOL1 FAM13A KCNJ10 PLCB1 PRKCE ABCC2 DNAJA1 | 2.27e-05 | 496 | 151 | 14 | int:SHANK3 |
| Interaction | ATP8A2 interactions | 3.35e-05 | 9 | 151 | 3 | int:ATP8A2 | |
| Interaction | SIRT7 interactions | MYO1D RTCB RPN2 ANKHD1 GDI2 PABPC1 NOP58 MYH14 EIF4A1 USP7 USP39 HERC2 ASCC3 DNAJA1 CNOT1 CAPRIN1 RBM34 | 4.40e-05 | 744 | 151 | 17 | int:SIRT7 |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.93e-04 | 19 | 109 | 3 | 832 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 7.08e-06 | 169 | 153 | 8 | M39230 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | EHBP1 SGTB ANK3 DSCAM ATP8A2 TMCC3 SLC12A5 OLFM3 PLCB1 SDC3 SYT4 PLCB4 RIMS1 PRKAG2 | 8.93e-06 | 584 | 153 | 14 | M39068 |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 2.23e-05 | 198 | 153 | 8 | M6109 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | MTMR1 HAUS3 ANKHD1 ITGB1 MIPOL1 LCTL BRCA2 EIF4A1 PLCB1 UGGT2 IFT80 ASCC3 CNOT1 CAPRIN1 RBM34 | 2.24e-05 | 721 | 153 | 15 | M10237 |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 2.40e-05 | 200 | 153 | 8 | M302 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | ITGB1 GDI2 TMCC3 ITPR1 MSI2 PARP4 BRCA2 MYH14 SMPDL3A CEP112 HECTD2 ATF7IP SDC3 RNF216 HERC2 ASCC3 CAPRIN1 CUX1 | 2.58e-05 | 1009 | 153 | 18 | M157 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | ANK3 FSTL5 MSI1 TRIM5 SLC12A5 MSI2 CIRBP CASD1 ATP8A1 SYT11 USP7 PRKCE PLCB4 HERC2 ASCC3 PRKAG2 CAPRIN1 CUX1 ADGRL3 | 6.39e-06 | 818 | 152 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | ARHGEF28 MYO1D ITPR1 PTCHD1 COL21A1 SLIT3 PLCB4 RIMS1 PLS3 ADGRL3 | 1.09e-09 | 188 | 153 | 10 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-08 | 177 | 153 | 9 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.99e-08 | 189 | 153 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.61e-08 | 195 | 153 | 9 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.61e-08 | 195 | 153 | 9 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-07 | 176 | 153 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.21e-07 | 181 | 153 | 8 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.95e-07 | 188 | 153 | 8 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 3.47e-07 | 192 | 153 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 3.47e-07 | 192 | 153 | 8 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.47e-07 | 192 | 153 | 8 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.61e-07 | 193 | 153 | 8 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-07 | 193 | 153 | 8 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-07 | 193 | 153 | 8 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-07 | 194 | 153 | 8 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-07 | 194 | 153 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.90e-07 | 195 | 153 | 8 | 43164511f32e4591cb5399182fbac0b911716233 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.90e-07 | 195 | 153 | 8 | 9337111d75a487abc02969337718c30b1fe81379 | |
| ToppCell | ileum-BEST4+_Enterocytes|ileum / shred on tissue and cell subclass | 1.07e-06 | 154 | 153 | 7 | 608e9c982125e0c2c15b86b1920813845a0db81f | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.91e-06 | 168 | 153 | 7 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.15e-06 | 171 | 153 | 7 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.51e-06 | 175 | 153 | 7 | 8a4ed775ff973123dbcfe9c809959d11a62450c9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 178 | 153 | 7 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-06 | 179 | 153 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 3.14e-06 | 181 | 153 | 7 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-06 | 182 | 153 | 7 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 3.37e-06 | 183 | 153 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | PND07-28-samps-Epithelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.37e-06 | 183 | 153 | 7 | a98f1d71d82ed6cca996f74352ab834fb6e95206 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.37e-06 | 183 | 153 | 7 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-06 | 184 | 153 | 7 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-06 | 184 | 153 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-06 | 184 | 153 | 7 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-06 | 186 | 153 | 7 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | Epithelial-C_(AT2)|World / shred on cell class and cell subclass (v4) | 3.76e-06 | 186 | 153 | 7 | b7b1763fc52b4485d843a4a6727055e6c95ebad3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-06 | 187 | 153 | 7 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.17e-06 | 189 | 153 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | PND14-Epithelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-06 | 190 | 153 | 7 | f1eeef8f201bf7b96c020c8ab53dd7e05b3060ea | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 4.47e-06 | 191 | 153 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.47e-06 | 191 | 153 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 4.63e-06 | 192 | 153 | 7 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.79e-06 | 193 | 153 | 7 | 1fdfe08b0c82248545c29b504ac259b093fde29b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.79e-06 | 193 | 153 | 7 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.79e-06 | 193 | 153 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.79e-06 | 193 | 153 | 7 | 5f90e3e526032d82d9dc7e0813fe79ca28dc0719 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.79e-06 | 193 | 153 | 7 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.95e-06 | 194 | 153 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 4.95e-06 | 194 | 153 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | PND01-Epithelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.95e-06 | 194 | 153 | 7 | d21db5e942966ed44bc78ff50130a201fc627074 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.12e-06 | 195 | 153 | 7 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.12e-06 | 195 | 153 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.12e-06 | 195 | 153 | 7 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 196 | 153 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.48e-06 | 197 | 153 | 7 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.66e-06 | 198 | 153 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.66e-06 | 198 | 153 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.66e-06 | 198 | 153 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.85e-06 | 199 | 153 | 7 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | distal-1-Epithelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.85e-06 | 199 | 153 | 7 | 9086dbb60863c3da2cc5d0a310f28596a01c52ca | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-06 | 199 | 153 | 7 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-06 | 199 | 153 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.05e-06 | 200 | 153 | 7 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 6.05e-06 | 200 | 153 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.05e-06 | 200 | 153 | 7 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.05e-06 | 200 | 153 | 7 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.05e-06 | 200 | 153 | 7 | b2d61bc3afac0d78aa30082760da5b1a15d1fad2 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.05e-06 | 200 | 153 | 7 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.05e-06 | 200 | 153 | 7 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.05e-06 | 200 | 153 | 7 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.05e-06 | 200 | 153 | 7 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-coronary_vascular_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 132 | 153 | 6 | dc13b54e38fbda9341972cef11833041f2f2a345 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|World / Lineage, cell class and subclass | 8.34e-06 | 80 | 153 | 5 | 9bd3ad5029eb84efcdbf08fe268c29fa9b0b302b | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.67e-05 | 156 | 153 | 6 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.73e-05 | 157 | 153 | 6 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 159 | 153 | 6 | 323cb4a2416d2e6bff0a3f225d2edeae9ab7dc76 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 160 | 153 | 6 | 9f24ee4fe1ba4590dce5dd4d43707fb007dca82f | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 160 | 153 | 6 | 3b3b99305558f5b49d050fb9b249007630ea9085 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-05 | 162 | 153 | 6 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-05 | 162 | 153 | 6 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 162 | 153 | 6 | 75df7ff779a3b9159ba97d852da1f8df650b9ce5 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.07e-05 | 162 | 153 | 6 | b115b5799137122bd60696f8ae2aebadad6cd044 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 2.30e-05 | 165 | 153 | 6 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-05 | 166 | 153 | 6 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.63e-05 | 169 | 153 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.72e-05 | 170 | 153 | 6 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.30e-05 | 176 | 153 | 6 | ac76f2cd6c63f30b38b89b58bad2baa4dde8ce3a | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-11|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-05 | 177 | 153 | 6 | 3535575686c9700ab72700aae6f2070ebbb50044 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.51e-05 | 178 | 153 | 6 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.63e-05 | 179 | 153 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-05 | 179 | 153 | 6 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 3.74e-05 | 180 | 153 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 3.74e-05 | 180 | 153 | 6 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.86e-05 | 181 | 153 | 6 | 986c036e656f24fe374807e2711cec9e3c83c892 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.86e-05 | 181 | 153 | 6 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 181 | 153 | 6 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | E18.5-samps|World / Age Group, Lineage, Cell class and subclass | 3.98e-05 | 182 | 153 | 6 | 9649f15858d1ede73e068afc59df3ac367b49687 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.98e-05 | 182 | 153 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.23e-05 | 184 | 153 | 6 | 49705c8fec565b16216bdf48e83e27521f52d99a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 4.36e-05 | 185 | 153 | 6 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-05 | 185 | 153 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.36e-05 | 185 | 153 | 6 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| Drug | sapintoxin A | 7.02e-06 | 19 | 153 | 4 | CID000108085 | |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 8.04e-06 | 198 | 153 | 9 | 3281_DN | |
| Drug | methylparaben | 8.74e-06 | 20 | 153 | 4 | CID000007456 | |
| Drug | AC1OAGGW | 9.82e-06 | 203 | 153 | 9 | CID006857364 | |
| Drug | lysosphingomyelin | 1.30e-05 | 160 | 153 | 8 | CID000005263 | |
| Drug | AC1OAGFB | CLTCL1 PLCD4 TRIP10 ITPR1 ART4 GLE1 KCNJ10 KCNJ15 PLCB1 SDC3 PRKCE PLCB4 PLS3 CUX1 | 1.73e-05 | 539 | 153 | 14 | CID006857345 |
| Drug | D-myo-inositol 1,4-bisphosphate | 2.52e-05 | 86 | 153 | 6 | CID000000805 | |
| Drug | papaverine | 2.59e-05 | 176 | 153 | 8 | CID000004680 | |
| Drug | reactive blue 2 | 2.69e-05 | 87 | 153 | 6 | CID000656725 | |
| Disease | Bipolar Disorder | CACNA1D ANK3 DSCAM ABCA13 FSTL5 ERVW-1 CLOCK F9 ITPR1 NOD2 BRCA2 PLCB1 RIMS1 ALDH2 | 1.53e-07 | 477 | 149 | 14 | C0005586 |
| Disease | asphyxiating thoracic dystrophy (implicated_via_orthology) | 2.53e-05 | 2 | 149 | 2 | DOID:0050592 (implicated_via_orthology) | |
| Disease | Calcium channel blocker use measurement | 1.09e-04 | 213 | 149 | 7 | EFO_0009930 | |
| Disease | clonal hematopoiesis mutation measurement | 1.74e-04 | 55 | 149 | 4 | EFO_0020949 | |
| Disease | idiopathic pulmonary fibrosis | 2.00e-04 | 57 | 149 | 4 | EFO_0000768 | |
| Disease | impulse control disorder | 3.75e-04 | 6 | 149 | 2 | MONDO_0001162 | |
| Disease | glycocholenate sulfate measurement | 3.75e-04 | 6 | 149 | 2 | EFO_0800276 | |
| Disease | response to angiotensin receptor blocker | 4.64e-04 | 30 | 149 | 3 | EFO_0010735 | |
| Disease | Manic Disorder | 4.67e-04 | 71 | 149 | 4 | C0024713 | |
| Disease | language measurement | 6.08e-04 | 134 | 149 | 5 | EFO_0007797 | |
| Disease | Manic | 6.66e-04 | 78 | 149 | 4 | C0338831 | |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 6.95e-04 | 8 | 149 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | Depression, Bipolar | 6.99e-04 | 79 | 149 | 4 | C0005587 | |
| Disease | 2-hydroxyglutaric acid measurement | 8.91e-04 | 9 | 149 | 2 | EFO_0010446 | |
| Disease | chronic kidney disease | 1.28e-03 | 235 | 149 | 6 | EFO_0003884 | |
| Disease | serum IgG glycosylation measurement | 1.41e-03 | 523 | 149 | 9 | EFO_0005193 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.62e-03 | 335 | 149 | 7 | EFO_0009931 | |
| Disease | JT interval | 1.68e-03 | 248 | 149 | 6 | EFO_0007885 | |
| Disease | Diuretic use measurement | 1.71e-03 | 169 | 149 | 5 | EFO_0009928 | |
| Disease | pulse pressure measurement | CACNA1D DSCAM PCDHA4 PCDHA2 MSI2 OLFM3 FAM13A COL21A1 SLIT3 SORCS3 SYT4 PRKCE IFT80 PRKAG2 CNOT1 ABCC10 | 1.85e-03 | 1392 | 149 | 16 | EFO_0005763 |
| Disease | 3-hydroxy-1-methylpropylmercapturic acid measurement | 2.14e-03 | 352 | 149 | 7 | EFO_0007015 | |
| Disease | blood urea nitrogen measurement | 2.17e-03 | 452 | 149 | 8 | EFO_0004741 | |
| Disease | Hamman-Rich syndrome | 2.21e-03 | 14 | 149 | 2 | C0085786 | |
| Disease | triacylglycerol 48:4 measurement | 2.21e-03 | 14 | 149 | 2 | EFO_0010407 | |
| Disease | Antihypertensive use measurement | 2.34e-03 | 265 | 149 | 6 | EFO_0009927 | |
| Disease | phosphatidylcholine 36:3 measurement | 2.55e-03 | 15 | 149 | 2 | EFO_0010381 | |
| Disease | susceptibility to common cold measurement | 2.59e-03 | 54 | 149 | 3 | EFO_0008417 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 2.80e-03 | 115 | 149 | 4 | EFO_0007878, EFO_0010724 | |
| Disease | Keratoderma, Palmoplantar | 2.90e-03 | 16 | 149 | 2 | C4551675 | |
| Disease | keratinocyte carcinoma | 3.07e-03 | 118 | 149 | 4 | EFO_0010176 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 3.67e-03 | 18 | 149 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 3.84e-03 | 62 | 149 | 3 | EFO_0803360, EFO_0803362 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.09e-03 | 19 | 149 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Usual Interstitial Pneumonia | 4.09e-03 | 19 | 149 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 4.09e-03 | 19 | 149 | 2 | C4721508 | |
| Disease | hydrocephalus (implicated_via_orthology) | 4.09e-03 | 19 | 149 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | Multiple Epiphyseal Dysplasia | 4.53e-03 | 20 | 149 | 2 | C0026760 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 4.53e-03 | 20 | 149 | 2 | C4721952 | |
| Disease | Grand Mal Status Epilepticus | 4.77e-03 | 67 | 149 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 4.77e-03 | 67 | 149 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 4.77e-03 | 67 | 149 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 4.77e-03 | 67 | 149 | 3 | C0751523 | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.77e-03 | 67 | 149 | 3 | C3463824 | |
| Disease | Petit mal status | 4.77e-03 | 67 | 149 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 4.77e-03 | 67 | 149 | 3 | C0393734 | |
| Disease | schizophrenia (implicated_via_orthology) | 4.98e-03 | 68 | 149 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Status Epilepticus | 4.98e-03 | 68 | 149 | 3 | C0038220 | |
| Disease | treatment resistant depression, response to antidepressant | 4.99e-03 | 21 | 149 | 2 | EFO_0009854, GO_0036276 | |
| Disease | Idiopathic Pulmonary Fibrosis | 4.99e-03 | 21 | 149 | 2 | C1800706 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DYNFPKKALVVTIQE | 166 | Q9BT88 | |
| GYFTALEQFIKEVVK | 306 | Q7L211 | |
| SGKVVDIYSKFDVIN | 466 | Q9UGJ0 | |
| QEKDQKYVFASVDSK | 716 | Q6ZSZ5 | |
| VFEVKGLETNEKYVF | 971 | Q96N23 | |
| QQAASLVIRKYEFEK | 441 | Q8IYX3 | |
| EQNYVPKFETAQLKD | 556 | Q8TC20 | |
| DRFIVVVKATKAYNQ | 126 | O00574 | |
| AAINKEFSNKVYLAD | 771 | Q9HAR2 | |
| FKRQVELNSEKVYAE | 606 | Q8N8E3 | |
| KVQYDLKSQFGFDDL | 271 | Q86UQ4 | |
| FTNVKELYGKIAEAF | 76 | O14908 | |
| QGLDFVQYKLAEKFV | 471 | Q53GS7 | |
| YFESQNVDFRGKKVI | 66 | Q96AZ1 | |
| EKLIKAFAEQIFYTG | 341 | Q3MIX3 | |
| YSFASIENNKVIIKD | 61 | Q15782 | |
| EGEKFKQISQAYEVL | 41 | P31689 | |
| VSKYQEVTNNLEFAK | 96 | Q14444 | |
| LNEELGQVKYIFSDK | 396 | Q9Y2Q0 | |
| NEELGQVKYLFSDKT | 416 | Q9NTI2 | |
| ENKQYLFSRVFEKGL | 636 | Q8TBY9 | |
| YKQEEQSKLGIFENL | 186 | Q13613 | |
| VEDAFLEAAKKIYQN | 161 | P61106 | |
| QKNINAYVVFKEESA | 241 | P42696 | |
| TVVEDVKQYFEQFGK | 121 | Q96DH6 | |
| TFDKNYKATIGVDFE | 76 | Q9BZG1 | |
| AVEIKQEGDTFYIKT | 41 | P29373 | |
| AVTEEFQPVYKELKN | 336 | P05556 | |
| RAKEFTNVYIKNFGE | 186 | P11940 | |
| NDNEPTFAQSVYKVK | 236 | Q9Y5H9 | |
| IFIQKKEEADYSAFG | 91 | Q9BYG5 | |
| FLQEKDQKYIFAAVD | 1116 | Q8N1W1 | |
| DQKYIFAAVDQKPSV | 1121 | Q8N1W1 | |
| NVLYEKEGEFVAQFK | 306 | Q9UQ80 | |
| QVKNFVKNYSDAEIK | 6 | Q8IYW4 | |
| FGKTFDAQLYKEVLE | 686 | Q5T3U5 | |
| ETSVGYAIFKVLNEK | 6 | Q9Y2X3 | |
| VYKKFDLGQDVIDFT | 171 | P50395 | |
| DFIVNKTGQEKLYFI | 156 | Q5VXI9 | |
| VKIEFQLQAYTDKQS | 131 | O15232 | |
| GKYIADFSLFDQVVK | 321 | P78508 | |
| VQYIKFLQTIVKAEG | 1316 | Q14643 | |
| EKTAALVEEVYFAQK | 161 | Q8TD10 | |
| TVIDGKVYDIKDFQT | 1226 | O95714 | |
| QFEKLDIYASQVTAK | 151 | Q8NBH2 | |
| IVKQINQEEFKGFSY | 716 | Q02156 | |
| IDIFQKYSDVIAGQF | 276 | Q92484 | |
| VFQEEFGIIKSYNLK | 586 | Q5U5R9 | |
| YNKEFAEVKNQEVTI | 136 | Q13948 | |
| GQEVFKSELSEYIKA | 491 | Q5JST6 | |
| GFKDQIYDIFQKLNS | 191 | P60842 | |
| YVQKAQTKEQADFAL | 426 | Q7Z406 | |
| RNKDGKISFDEFVYI | 66 | P13797 | |
| ENEFVTIKKDVDGAY | 281 | P04264 | |
| QVNKKGIEFYSDLID | 126 | Q6UWM7 | |
| KIAELIYKEFFSQGD | 821 | O00408 | |
| IADKEYTNIFLKFGS | 336 | P00740 | |
| KEVEQFTQVAKAYQD | 121 | O96000 | |
| GKYVADFSQFEQIRK | 321 | Q99712 | |
| YRFKDVAEIQTKGFQ | 636 | Q5S007 | |
| EQIEKAFNYASKVLL | 486 | Q9BSJ2 | |
| KDNILFGTEFNEKRY | 716 | Q92887 | |
| SEFVPKVYNQIKEFI | 491 | Q9Y2D4 | |
| PQDFEVAKYNTLEKV | 146 | Q9UKK3 | |
| EQKDFTYQKLFGVSL | 31 | O94988 | |
| TVEDVKQYFEQFGKV | 121 | O43347 | |
| AVNVKDKFIYVAQPT | 506 | Q8N475 | |
| NEYVFRETVNKKEGL | 241 | Q8TCB7 | |
| QQFESYKEQVRKIGE | 86 | Q86UR5 | |
| QVKLTFENAYDVKRE | 256 | Q9ULD6 | |
| LQDGKFASVFVYKRE | 31 | Q8IZE3 | |
| QIIVKGYIDFEESKS | 301 | Q9UN74 | |
| GVSVKQQFTEEEIYK | 156 | Q8N7H5 | |
| LAYRQKFLETFGKQE | 716 | Q9P2H3 | |
| IYKAFIKESGIQFSE | 516 | Q8NB78 | |
| VLGVFYNENTKETKV | 411 | Q96PB1 | |
| VKLSKVLNFYVANAD | 731 | Q9H7D0 | |
| NQVKEKYSFVSEVEP | 346 | P51587 | |
| VNEETKLVYFQGTKD | 506 | Q86TI2 | |
| KYSGKEETVQFDVQK | 391 | Q96P44 | |
| LYTKKQFFQGIHEVV | 216 | Q68CZ6 | |
| VSFVQVGKQYEKEIQ | 3096 | Q12955 | |
| EVLNKGFKDTSQYVV | 1061 | Q8NDI1 | |
| EYEAEFQVKITAKGD | 576 | Q6VMQ6 | |
| TQKGIDKEFYLLFTV | 571 | Q6MZM0 | |
| VLKDVQRSYEGKEFQ | 1016 | A6NE01 | |
| EEYIQFKQFAGKHVL | 51 | P59796 | |
| QASVTYQKPDKQEEF | 426 | O75056 | |
| VIVTFQEQGEKEYKN | 1151 | Q01668 | |
| TNNKIVREYKSIADF | 261 | Q96PB7 | |
| TVVFVGVKYVNKFAL | 266 | Q9H2X9 | |
| QNKLFESIQEGKYEF | 321 | Q9BUB5 | |
| QDQGKFIALFYTVVT | 271 | O76001 | |
| FVRKDKLSAQDYVQV | 386 | O60469 | |
| FDEQEKGIVTKFYQL | 396 | Q9Y2M0 | |
| EDRKGFTKLVYQNIF | 66 | O95837 | |
| DESVKEKYAGQDIVF | 66 | Q9NQT8 | |
| IQVVDEIFNEYAAKK | 231 | Q9Y3I0 | |
| LEYNFERKAFVVNIK | 161 | Q9H2B2 | |
| KVQDAFISYRQSIDK | 296 | O14607 | |
| IENIYAEGFIKTFQD | 1746 | Q9C093 | |
| YYVNQSGIVTEKVKE | 406 | Q9UQF0 | |
| AKYQEFETKENILVN | 666 | O60522 | |
| QFLSDKKIGTYVEVD | 711 | Q15147 | |
| VQFYKALTKRAEVQE | 196 | Q9BRC7 | |
| LKVQFKREYGFISQT | 311 | Q9ULS5 | |
| KNVFNPKRVVEDSEY | 346 | Q9H4L7 | |
| FNILAKFNGITEKEY | 416 | Q53GS9 | |
| FALEKTFEQTKYLAG | 161 | Q9C056 | |
| NKGIEVFYKIQEDVY | 366 | Q9H3E2 | |
| IFLANKKVDDQVKTY | 501 | Q9UPU3 | |
| IFSKKYNDEVDVVAS | 631 | Q96NR3 | |
| VQVRKYGEQKTLFIF | 126 | Q9NPR9 | |
| IDVSIGDFQKEYQLK | 126 | Q86UG4 | |
| SYIDFKFEQGDIKIE | 436 | Q9NWF9 | |
| EVNKNVKFTAQEIYD | 836 | Q5T5J6 | |
| GDFQDLNTKYVKSII | 86 | Q9NZI6 | |
| YLNKETIGKFFQADI | 106 | Q5TEU4 | |
| QVDETQFKKILGYIN | 361 | P05091 | |
| FLQEIKNAKSEASIY | 676 | Q8TBZ0 | |
| QQFTKEYLETKGQKD | 851 | Q8IWZ3 | |
| FQQGVIKKNEFKIVY | 521 | Q8N3C0 | |
| EYVKFIGNFKSLNSV | 211 | O15516 | |
| FVKERTEVEQAYAKQ | 31 | Q15642 | |
| QALVELFESFKSYKG | 696 | P53675 | |
| FSKYGQISEVVVVKD | 26 | Q14011 | |
| KFLQDITDAEKYFIG | 116 | Q9NY25 | |
| AEVGQYEQVKQLFSF | 461 | A5YKK6 | |
| VEVKYVDFGNTAKIT | 756 | Q9BXT8 | |
| KLITVNFVGKDSYVE | 1156 | O75094 | |
| ILKGDFNYLEEFKQQ | 2356 | Q96JI7 | |
| KTQIQYDKTNVLADF | 171 | Q9C035 | |
| NTQIKYISEEDFKGL | 231 | Q9NR97 | |
| FIVDLFQGQYKSKLV | 641 | O94966 | |
| KYIRTEFNLKGFSEQ | 436 | Q9HC29 | |
| LQIGDIKTAEKYFQD | 591 | Q8WVT3 | |
| KYFQDVEKVTQKLDG | 601 | Q8WVT3 | |
| EVFESVSAYKNLQIK | 561 | P50443 | |
| EVVFVAEPDNKNVYK | 446 | P04844 | |
| YDKFDVEIKNVQLLF | 746 | Q709C8 | |
| TGKNYKIEFILDNVV | 4161 | Q86WI1 | |
| SFGKQVVEKVETEYA | 336 | Q15561 | |
| QFLSDKKVGTYVEVD | 686 | Q9NQ66 | |
| LNKFEEAVTSYQKAL | 166 | Q96EQ0 | |
| YVSLQEKDIFVSGVK | 66 | Q9NV66 | |
| FEKKYNTVGVNIFRT | 841 | Q9NYU1 | |
| IGFNVETVEYKNLKF | 436 | P36406 | |
| GKKNIFESFVDYVAV | 356 | Q93009 | |
| KYDVFGKIFNSSINI | 71 | Q86T29 | |
| QQSQVEKYKTLFEEA | 246 | Q8N6V9 | |
| VAQEYQEKFQESLKK | 136 | Q9C030 | |
| KESQAKEQYEQILAF | 196 | P41091 | |
| TGFVENINTILKEYK | 346 | Q96M32 | |
| DVVYSVIGFIDKNKD | 511 | O94832 | |
| KLTQGDYFTKDIEAQ | 76 | Q93070 |